Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04492202
Other study ID # 00010
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date August 1, 2020
Est. completion date December 10, 2020

Study information

Verified date July 2020
Source Istinye University
Contact Yasemin ÇIRAK, Assoc. Prof.
Phone 0544 3759723
Email ycirak@istinye.edu.tr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to evaluate the knowledge level of healthcare professionals such as physicians, nurses, physiotherapists and nutritionist about published COVID-19 guidelines.

The listed healthcare workers are take part in the primary treatment of the Corona virus infected patients in hospitals. Therefore the knowledge of the world wide spreading Corona Virus and its effects for the human being is should be known for the effective treatment and for raising public awareness.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date December 10, 2020
Est. primary completion date November 20, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years to 75 Years
Eligibility Inclusion Criteria:

- Physicians, nurses, physiotherapists and other healthcare professionals with clinical practical experience

- Actively working in the hospitals and in any health institution

Exclusion Criteria:

- Employees outside the health area

- Health professionals who do not work in any health institution

- Employees who do not have a bachelor's degree

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey
The survey will be sent to health professionals via online link.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istinye University

Outcome

Type Measure Description Time frame Safety issue
Other Fear of COVID-19 Scale The emergence of the COVID-19 and its consequences has led to fears, worries, and anxiety among individuals and health professionals worldwide. The Fear of COVID-19 Scale (FCV-19S) was developed to complement the clinical efforts in preventing the spread and treating of COVID-19 cases. We are going to evaluate the fear of COVID-19 in health professionals. 4 weeks
Primary Questionnaire for the Evaluation of Knowledge, Attitude and Practise Levels of Healthcare Professionals for COVID-19 The purpose of the knowledge, attitude and practise questionnaire; to measure the knowledge, attitude and skill levels of healthcare professionals against the COVID-19 virus. In addition, this study will demonstrate the change in the knowledge, attitudes and practise of different healthcare professionals regarding COVID-19. This questionnaire was developed by Istinye University Faculty of Health Science, Physiotherapy and Rehabilitation Department. 4 weeks
Secondary Support Approach Survey for Patients in Recovery Stage after COVID-19 Diagnosis This questionnaire has been used to evaluate the knowledge and guidance of healthcare professionals about which best approaches can be used to support patients who have had COVID-19 diagnosis and recovered. This questionnaire was developed by Istinye University Faculty of Health Science, Physiotherapy and Rehabilitation Department. 4 weeks
See also
  Status Clinical Trial Phase
Terminated NCT04558125 - Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism Phase 4
Recruiting NCT04410510 - P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 Phase 2/Phase 3
Active, not recruiting NCT04420676 - Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection N/A
Completed NCT04419025 - Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease Phase 2
Completed NCT04425317 - Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients N/A
Completed NCT04395911 - Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections N/A
Withdrawn NCT04456426 - Characteristics of Patients With COVID-19 in Meta State, Colombia
Completed NCT04526769 - Detecting SARS-CoV-2 in Tears
Suspended NCT04385771 - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation N/A
Completed NCT04425720 - Use of Remote Monitoring for COVID-19 Patient N/A
Completed NCT04419610 - RAS and Coagulopathy in COVID19 Early Phase 1
Completed NCT04546581 - Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) Phase 3
Terminated NCT04530448 - Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization Phase 4
Completed NCT04435327 - Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Not yet recruiting NCT04524156 - COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2 N/A
Completed NCT04441710 - Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus
Completed NCT04357834 - WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
Not yet recruiting NCT04392427 - New Antiviral Drugs for Treatment of COVID-19 Phase 3
Terminated NCT04614025 - Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19 Phase 2
Completed NCT04402957 - LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) Phase 2